PL433613A1 - Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood - Google Patents

Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood

Info

Publication number
PL433613A1
PL433613A1 PL433613A PL43361320A PL433613A1 PL 433613 A1 PL433613 A1 PL 433613A1 PL 433613 A PL433613 A PL 433613A PL 43361320 A PL43361320 A PL 43361320A PL 433613 A1 PL433613 A1 PL 433613A1
Authority
PL
Poland
Prior art keywords
copper
cancer
likelihood
determining
lung cancer
Prior art date
Application number
PL433613A
Other languages
Polish (pl)
Inventor
Jan LUBIŃSKI
Cezary Cybulski
Jacek Gronwald
Tomasz Huzarski
Katarzyna Białkowska
Róża Derkacz
Wojciech MARCINIAK
Anna Jakubowska
Original Assignee
Read-Geng Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Read-Geng Spółka Akcyjna filed Critical Read-Geng Spółka Akcyjna
Priority to PL433613A priority Critical patent/PL433613A1/en
Publication of PL433613A1 publication Critical patent/PL433613A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób określenia prawdopodobieństwa wystąpienia raka płuca u kobiet, charakteryzujący się tym, że obejmuje ilościową ocenę stężenia miedzi we krwi pełnej osoby badanej, przy czym stężenie wskazuje na jedenastokrotnie podwyższoną częstość występowania raka płuca w stosunku do podgrupy (kwartyla) o najniższym stężeniu miedzi we krwi, w przypadku występowania wartości stężenia miedzi we krwi powyżej 1100 µg/l.The subject of the report is a method of determining the likelihood of lung cancer in women, characterized by the fact that it includes the quantification of the concentration of copper in the whole blood of the subject, the concentration indicating an eleven times higher incidence of lung cancer in relation to the subgroup (quartile) with the lowest copper concentration. in the blood when the blood copper concentration is above 1100 µg / l.

PL433613A 2020-04-21 2020-04-21 Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood PL433613A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL433613A PL433613A1 (en) 2020-04-21 2020-04-21 Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL433613A PL433613A1 (en) 2020-04-21 2020-04-21 Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood

Publications (1)

Publication Number Publication Date
PL433613A1 true PL433613A1 (en) 2021-10-25

Family

ID=78572538

Family Applications (1)

Application Number Title Priority Date Filing Date
PL433613A PL433613A1 (en) 2020-04-21 2020-04-21 Method of determining the likelihood of lung cancer and colerectal cancer in women based on the assessment of copper in whole blood

Country Status (1)

Country Link
PL (1) PL433613A1 (en)

Similar Documents

Publication Publication Date Title
Shin et al. Comprehensive interpretation of central venous oxygen saturation and blood lactate levels during resuscitation of patients with severe sepsis and septic shock in the emergency department
AR115214A1 (en) METHODS AND TEST KITS TO DETERMINE THE STATUS OF MALE FERTILITY
PL440972A1 (en) Method of determining the risk of cancer in women depending on the ratio of selenium to arsenic concentrations in blood
Ni et al. Detection of circulating tumour cells may add value in endometrial cancer management
Nobles et al. Correlation of urine and plasma cytokine levels among reproductive‐aged women
PL437046A1 (en) Serum arsenic, zinc and selenium concentration as a marker of survival in patients with prostate cancer in Poland
PL437571A1 (en) Method for determining the risk of cancers in women, depending on concentration of zinc in the blood
PL437898A1 (en) Way to determine the risk of cancer in men depending on the concentration of selenium in the blood
PL437897A1 (en) Way to determine the risk of cancer in men according to the concentration of cadmium in the blood
PL437895A1 (en) Way to determine the risk of cancer in men according to the concentration of copper in the blood
PL438655A1 (en) Method of determining the risk of cancer in women depending on concentration of lead in the blood
Cheekuri et al. Hyperbilirubinemia as a predictor of the severity of acute appendicitis-an observational study
Golbahar et al. Normal range of total plasma homocysteine concentrations in southern Iran
Guideline Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
Wang et al. Association of folate deficiency and selected tumor marker concentrations in long-term hexavalent chromium exposed population
PL437899A1 (en) Way to determine the risk of cancer in men according to the concentration of lead in the blood
PL437894A1 (en) Way to determine the risk of cancer in men according to the concentration of zinc in the blood
이태우 et al. The effects of exposure to lead, cadmium and mercury on follicle-stimulating hormone levels in men and postmenopausal women: data from the Second Korean National Environmental Health Survey (2012–2014)
Barya et al. Neutrophil-–lymphocytic ratio (NLR) or albumin-globulin ratio (AGR) which one is a better predictor marker in assessment of severity of COVID-19 infection
PL446712A1 (en) Correlation between serum selenium and zinc concentrations as a prognostic marker in patients with prostate cancer
Singangutti Incidence and etiologic factors responsible for anovulation in infertility cases
Gao et al. Over-education in China
Jusufovic et al. Ferritin and LDH as predictors of mortality in COVID-19 infection, Bosnia and Herzegovina single-center study
PL441999A1 (en) Method of determining the risk of cancer in men depending on the ratio of concentrations of selected elements in the blood
PL432207A1 (en) Device for testing the durability of turn window fittings